Prasco LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Prasco LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7535
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Prasco LLC (Prasco Laboratories) is a pharmaceutical company that manufactures and markets authorized generic and generic products. The company’s authorized generic products include acitretin capsules, clotrimazole and betamethasone dipropionate cream, atovaquone and proguanil HCl tablets, calcipotriene cream, and carbamazepine extended-release capsules. It also provides augmented betamethasone dipropionate, levalbuterol HCl inhalation solution, mirtazapine orally disintegrating tablets and mupirocin calcium cream, among others. Prasco Laboratories’ generic products comprise duloxetine delayed release capsules, olanzapine orally disintegrating tablets, raloxifene Hcl, pantoprazole sodium delayed-release tablets, and olanzapine tablets. The company partners with various pharmaceutical companies for manufacturing authorized generic products. It has operations in Cincinnati and Washington D.C., the US. Prasco Laboratories is headquartered in Mason, Ohio, the US.

Prasco LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Prasco LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Prasco LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Prasco LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Prasco LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Prasco LLC, Medical Devices Deals, 2012 to YTD 2018 9
Prasco LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Prasco LLC, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Prasco to Acquire Authorized Generic of Adderall XR Capsules from Teva Pharma and Shire 11
Partnerships 13
Prasco Lab Enters into Co-Marketing Agreement with Takeda Pharma 13
Prasco Labs Enters into Distribution Agreement with Recordati Rare Diseases 14
Prasco Labs Enters Into Distribution Agreement With Eli Lilly For Evista 15
Prasco Labs Enters Into Agreement With Shire For Distribution Of Fosrenol 16
Prasco Labs Enters Into Distribution Agreement With WellSpring Pharma For Phenoxybenzamine Hydrochloride Capsules 17
Prasco Labs Enters into Distribution Agreement with Sunovion Pharma for Xopenex 18
ViroPharma Enters Into Co-Marketing Agreement With Prasco Labs For Vancocin 19
Prasco Labs Enters Into Co-Marketing Agreement With Shire For Carbatrol 20
Asset Transactions 21
IGI Labs Acquires Econazole Nitrate Cream From Prasco 21
Acquisition 22
Prasco Laboratories Acquires Additional stake in Aprecia Pharma 22
Prasco LLC – Key Competitors 23
Prasco LLC – Key Employees 24
Prasco LLC – Locations And Subsidiaries 25
Head Office 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Prasco LLC, Pharmaceuticals & Healthcare, Key Facts 2
Prasco LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Prasco LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Prasco LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Prasco LLC, Deals By Therapy Area, 2012 to YTD 2018 8
Prasco LLC, Medical Devices Deals, 2012 to YTD 2018 9
Prasco LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Prasco to Acquire Authorized Generic of Adderall XR Capsules from Teva Pharma and Shire 11
Prasco Lab Enters into Co-Marketing Agreement with Takeda Pharma 13
Prasco Labs Enters into Distribution Agreement with Recordati Rare Diseases 14
Prasco Labs Enters Into Distribution Agreement With Eli Lilly For Evista 15
Prasco Labs Enters Into Agreement With Shire For Distribution Of Fosrenol 16
Prasco Labs Enters Into Distribution Agreement With WellSpring Pharma For Phenoxybenzamine Hydrochloride Capsules 17
Prasco Labs Enters into Distribution Agreement with Sunovion Pharma for Xopenex 18
ViroPharma Enters Into Co-Marketing Agreement With Prasco Labs For Vancocin 19
Prasco Labs Enters Into Co-Marketing Agreement With Shire For Carbatrol 20
IGI Labs Acquires Econazole Nitrate Cream From Prasco 21
Prasco Laboratories Acquires Additional stake in Aprecia Pharma 22
Prasco LLC, Key Competitors 23
Prasco LLC, Key Employees 24

List of Figures
Prasco LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Prasco LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Prasco LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Prasco LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Prasco LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Prasco LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Prasco LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Prasco LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Prasco LLC, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Prasco LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • AutoCanada Inc.:企業のM&A・事業提携・投資動向
    AutoCanada Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's AutoCanada Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Clear Lam Packaging, Inc.:企業の戦略・SWOT・財務情報
    Clear Lam Packaging, Inc. - Strategy, SWOT and Corporate Finance Report Summary Clear Lam Packaging, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Rogers Corp (ROG):企業の財務・戦略的SWOT分析
    Summary Rogers Corp (Rogers) is a diversified company. The company offers advanced connectivity solutions, elastomeric solutions, power electronic solutions and performance materials. Its advanced connectivity solutions include laminates, bond ply or prepreg, copper clad laminates and conductive adh …
  • Biofortuna Ltd:企業の製品パイプライン分析2018
    Summary Biofortuna Ltd (Biofortuna) is a provider of contract services and molecular diagnostic products. The company distributes CE-marked and freeze-dried PCR diagnostic kits. It has freeze dried molecular diagnostic products targeted at the transplantation, disease identification and pharmacogene …
  • Presbia Plc (LENS):医療機器:M&Aディール及び事業提携情報
    Summary Presbia Plc (Presbia) is a medical device company. The company develops presbyopia-correcting presbia flexivue microlens, a solutions for the age-related loss of the ability to read or focus on near objects. Its microlens helps people to read newspapers, restaurant menus, cell phone messages …
  • BioTime Inc (BTX)-製薬・医療分野:企業M&A・提携分析
    Summary BioTime Inc (BioTime) is a biotechnology company which focuses on regenerative medicine and plasma volume expanders. The company’s Hextend is a blood plasma volume expander used for the treatment of hypovolemia in surgery, emergency trauma treatment, and other applications. It is also develo …
  • Mulberry Group PLC (MUL):企業の財務・戦略的SWOT分析
    Mulberry Group PLC (MUL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • HCL Infosystems Limited:企業の戦略・SWOT・財務分析
    HCL Infosystems Limited - Strategy, SWOT and Corporate Finance Report Summary HCL Infosystems Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Poslovni sistem Mercator, d.d.:企業のM&A・事業提携・投資動向
    Poslovni sistem Mercator, d.d. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Poslovni sistem Mercator, d.d. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Tanfield Group PLC (TAN):企業の財務・戦略的SWOT分析
    Summary Tanfield Group plc (Tanfield Group) is an investment company that offers electrical investments. The company designs and produces electric commercial vehicles for short haul urban fleets. It also produces zero-emission vehicles that deliver better performance to traditional diesel trucks. Ta …
  • ALPCO Diagnostics-医療機器分野:企業M&A・提携分析
    Summary ALPCO Diagnostics (ALPCO) is a lifescience company that imports and distributes immunoassay based products. The company’s products include immunoassays, chemiluminescent assays, flow cytometry reagents, purified antibodies, recombinant proteins, and HPLC and MS-MS reagents. It also provides …
  • I-O Data Device, Inc. (6916):企業の財務・戦略的SWOT分析
    I-O Data Device, Inc. (6916) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Country Club Hospitality & Holidays Ltd.
    Country Club Hospitality & Holidays Ltd. - Strategy, SWOT and Corporate Finance Report Summary Country Club Hospitality & Holidays Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Guernsey Electricity Ltd:企業の戦略的SWOT分析
    Guernsey Electricity Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Chromalloy Gas Turbine LLC:戦略・SWOT・企業財務分析
    Chromalloy Gas Turbine LLC - Strategy, SWOT and Corporate Finance Report Summary Chromalloy Gas Turbine LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • SMBC Trust Bank Private Banking:企業の戦略・SWOT・財務分析
    SMBC Trust Bank Private Banking - Strategy, SWOT and Corporate Finance Report Summary SMBC Trust Bank Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Enterprise Ireland:医療機器:M&Aディール及び事業提携情報
    Summary Enterprise Ireland (EI) is an economic development organization that offers enterprise development programs. The organization’s activities include funding supports, export assistance, supports to develop competitiveness, incentives to stimulate in-company research and development, assistance …
  • CytoSorbents Corp (CTSO)-医療機器分野:企業M&A・提携分析
    Summary CytoSorbents Corp (CytoSorbents), formerly MedaSorb Technologies Corp, is a critical care immunotherapy company that specializes in the development of blood purification products. Its flagship product, CytoSorb is an extracorporeal cytokine adsorber that is designed to control extreme system …
  • Benesse Holdings, Inc. (9783):企業の財務・戦略的SWOT分析
    Benesse Holdings, Inc. (9783) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Mothercare plc (MTC):企業の財務・戦略的SWOT分析
    Mothercare plc (MTC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆